This market snapshot provides an analysis of the global market for transcatheter pulmonary valve devices. Pulmonary valve replacement is performed primarily for the treatment of pulmonary valve stenosis, a relatively rare disease associated with congenital heart defects. Devices covered within the scope of this analysis include transcatheter pulmonary valve implants for valve repair and replacement.
This market snapshot is intended to provide a high-level overview of the global market for transcatheter pulmonary valve devices, with key insights into:
- Unit volumes from 2021 to 2027
- Market forecasts from 2021 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- Edwards Lifesciences
- Medtronic
- PolyVascular
- Venus Medtech
